TY - JOUR
T1 - The Abbott Pandemic Defense Coalition
T2 - a unique multisector approach adds to global pandemic preparedness efforts
AU - Averhoff, Francisco
AU - Berg, Michael
AU - Rodgers, Mary
AU - Osmanov, Saladin
AU - Luo, Xinxin
AU - Anderson, Mark
AU - Meyer, Todd
AU - Landay, Alan
AU - Gamkrelidze, Amiran
AU - Kallas, Esper G.
AU - Ciuoderis, Karl
AU - Hernandez, Juan Pablo
AU - Henry, Jean Hugues
AU - Osorio, Jorge
AU - Lindo, John
AU - Deshommes, Johnson
AU - Anzinger, Joshua
AU - Manasa, Justen
AU - Alkashvili, Maia
AU - Souleyman, Mboup
AU - Kaleebu, Pontiano
AU - Correa-Oliveira, Rodrigo
AU - Solomon, Sunil
AU - de Olivera, Tulio
AU - Suputtamongkol, Yupin
AU - Cloherty, Gavin
N1 - Funding Information:
This work is supported by Abbott Diagnostics.
Publisher Copyright:
© 2022 The Author(s)
PY - 2022/4
Y1 - 2022/4
N2 - Detection and epidemiologic characterization of infectious disease outbreaks are key for early identification and response to potential pandemic threats. The rapid global spread of severe SARS-CoV-2 in 2020 highlighted the critical role of diagnostics in understanding the epidemiology of the virus early in the pandemic. As a natural extension of Abbott's work in diagnostics, virus discovery, and virus surveillance, the Abbott Pandemic Defense Coalition (APDC) was launched in early 2021. The APDC is a global multisector scientific and public health partnership whose primary objective is the early detection and mitigation of infectious disease threats of pandemic potential. As of January 2022, the APDC network has partners on 5 continents including academic institutions, governmental, and nongovernmental organizations. A novel element of the APDC is the capacity for early development and rapid deployment of scalable, quality diagnostics targeting newly identified pathogens of pandemic potential.
AB - Detection and epidemiologic characterization of infectious disease outbreaks are key for early identification and response to potential pandemic threats. The rapid global spread of severe SARS-CoV-2 in 2020 highlighted the critical role of diagnostics in understanding the epidemiology of the virus early in the pandemic. As a natural extension of Abbott's work in diagnostics, virus discovery, and virus surveillance, the Abbott Pandemic Defense Coalition (APDC) was launched in early 2021. The APDC is a global multisector scientific and public health partnership whose primary objective is the early detection and mitigation of infectious disease threats of pandemic potential. As of January 2022, the APDC network has partners on 5 continents including academic institutions, governmental, and nongovernmental organizations. A novel element of the APDC is the capacity for early development and rapid deployment of scalable, quality diagnostics targeting newly identified pathogens of pandemic potential.
KW - Pandemic preparedness
KW - emerging pathogens, virus discovery, surveillance, public health
UR - http://www.scopus.com/inward/record.url?scp=85125527916&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125527916&partnerID=8YFLogxK
U2 - 10.1016/j.ijid.2022.02.001
DO - 10.1016/j.ijid.2022.02.001
M3 - Short survey
C2 - 35134559
AN - SCOPUS:85125527916
SN - 1201-9712
VL - 117
SP - 356
EP - 360
JO - International Journal of Infectious Diseases
JF - International Journal of Infectious Diseases
ER -